Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. China Oncology Drugs Market


6. Market Share – China Oncology Drugs Market

6.1 By Therapy
6.2 By Indication
6.3 By Drugs


7. Therapy – China Oncology Drugs Market

7.1 Chemotherapy
7.2 Targeted Therapy
7.3 Immunotherapy (Biologic Therapy)
7.4 Hormonal Therapy


8. Indication – China Oncology Drugs Market

8.1 Blood Oncology
8.2 Breast Oncology
8.3 Gastrointestinal Oncology
8.4 Prostate Oncology
8.5 Lung Oncology
8.6 Skin Oncology
8.7 Ovarian Oncology
8.8 Cervical Oncology
8.9 Kidney Oncology
8.10 Other Oncology


9. Drugs – China Oncology Drugs Market

9.1 ESAs (Erythropoiesis Stimulating Agents)
9.2 G-CSFs (Granulocyte-colony Stimulating Factors)
9.3 Anti-emetics
9.4 Bisphosphonates
9.5 Opioids
9.6 NSAIDs & Others


10. Porter’s Five Forces Analysis – China Oncology Drugs Market

10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. SWOT Analysis – China Oncology Drugs Market

11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat


12. Company Analysis

12.1 Bristol Myers Squibb

12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue Analysis

12.2 Merck

12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue Analysis

12.3 Eli Lilly

12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue Analysis

12.4 Sino BioPharma

12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue Analysis

12.5 F Hoffmann-La Roche AG

12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue Analysis

12.6 Johnson & Johnson

12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue Analysis

12.7 AbbVie Inc.

12.7.1 Overview
12.7.2 Recent Development
12.7.3 Revenue Analysis

12.8 AstraZeneca plc

12.8.1 Overview
12.8.2 Recent Development
12.8.3 Revenue Analysis



List of Figures

Figure-01: China – Oncology Drugs Market (Billion US$), 2018 – 2023
Figure-02: China – Forecast for Oncology Drugs Market (Billion US$), 2024 – 2028
Figure-03: Therapy – Chemotherapy Market (Billion US$), 2018 – 2023
Figure-04: Therapy – Forecast for Chemotherapy Market (Billion US$), 2024 – 2028
Figure-05: Therapy – Targeted Therapy Market (Billion US$), 2018 – 2023
Figure-06: Therapy – Forecast for Targeted Therapy Market (Billion US$), 2024 – 2028
Figure-07: Therapy – Immunotherapy (Biologic Therapy) Market (Billion US$), 2018 – 2023
Figure-08: Therapy – Forecast for Immunotherapy (Biologic Therapy) Market (Billion US$), 2024 – 2028
Figure-09: Therapy – Hormonal Therapy Market (Billion US$), 2018 – 2023
Figure-10: Therapy – Forecast for Hormonal Therapy Market (Billion US$), 2024 – 2028
Figure-11: Indication – Blood Oncology Market (Billion US$), 2018 – 2023
Figure-12: Indication – Forecast for Blood Oncology Market (Billion US$), 2024 – 2028
Figure-13: Indication – Breast Oncology Market (Billion US$), 2018 – 2023
Figure-14: Indication – Forecast for Breast Oncology Market (Billion US$), 2024 – 2028
Figure-15: Indication – Gastrointestinal Oncology Market (Billion US$), 2018 – 2023
Figure-16: Indication – Forecast for Gastrointestinal Oncology Market (Billion US$), 2024 – 2028
Figure-17: Indication – Prostate Oncology Market (Billion US$), 2018 – 2023
Figure-18: Indication – Forecast for Prostate Oncology Market (Billion US$), 2024 – 2028
Figure-19: Indication – Lung Oncology Market (Billion US$), 2018 – 2023
Figure-20: Indication – Forecast for Lung Oncology Market (Billion US$), 2024 – 2028
Figure-21: Indication – Skin Oncology Market (Billion US$), 2018 – 2023
Figure-22: Indication – Forecast for Skin Oncology Market (Billion US$), 2024 – 2028
Figure-23: Indication – Ovarian Oncology Market (Billion US$), 2018 – 2023
Figure-24: Indication – Forecast for Ovarian Oncology Market (Billion US$), 2024 – 2028
Figure-25: Indication – Cervical Oncology Market (Million US$), 2018 – 2023
Figure-26: Indication – Forecast for Cervical Oncology Market (Million US$), 2024 – 2028
Figure-27: Indication – Kidney Oncology Market (Billion US$), 2018 – 2023
Figure-28: Indication – Forecast for Kidney Oncology Market (Billion US$), 2024 – 2028
Figure-29: Indication – Other Oncology Market (Billion US$), 2018 – 2023
Figure-30: Indication – Forecast for Other Oncology Market (Billion US$), 2024 – 2028
Figure-31: Drugs – ESAs (Erythropoiesis Stimulating Agents) Market (Billion US$), 2018 – 2023
Figure-32: Drugs – Forecast for ESAs (Erythropoiesis Stimulating Agents) Market (Billion US$), 2024 – 2028
Figure-33: Drugs – G-CSFs (Granulocyte-colony Stimulating Factors) Market (Billion US$), 2018 – 2023
Figure-34: Drugs – Forecast for G-CSFs (Granulocyte-colony Stimulating Factors) Market (Billion US$), 2024 – 2028
Figure-35: Drugs – Anti-emetics Market (Billion US$), 2018 – 2023
Figure-36: Drugs – Forecast for Anti-emetics Market (Billion US$), 2024 – 2028
Figure-37: Drugs – Bisphosphonates Market (Billion US$), 2018 – 2023
Figure-38: Drugs – Forecast for Bisphosphonates Market (Billion US$), 2024 – 2028
Figure-39: Drugs – Opioids Market (Billion US$), 2018 – 2023
Figure-40: Drugs – Forecast for Opioids Market (Billion US$), 2024 – 2028
Figure-41: Drugs – NSAIDs & Others Market (Billion US$), 2018 – 2023
Figure-42: Drugs – Forecast for NSAIDs & Others Market (Billion US$), 2024 – 2028
Figure-43: Bristol Myers Squibb – Global Revenue Market (Billion US$), 2018 – 2023
Figure-44: Bristol Myers Squibb – Forecast for Global Revenue Market (Billion US$), 2024 – 2028
Figure-45: Merck – Global Revenue Market (Billion US$), 2018 – 2023
Figure-46: Merck – Forecast for Global Revenue Market (Billion US$), 2024 – 2028
Figure-47: Eli Lilly – Global Revenue Market (Billion US$), 2018 – 2023
Figure-48: Eli Lilly – Forecast for Global Revenue Market (Billion US$), 2024 – 2028
Figure-49: Sino BioPharma – Global Revenue Market (Billion US$), 2018 – 2023
Figure-50: Sino BioPharma – Forecast for Global Revenue Market (Billion US$), 2024 – 2028
Figure-51: F Hoffmann-La Roche AG – Global Revenue Market (Billion US$), 2018 – 2023
Figure-52: F Hoffmann-La Roche AG – Forecast for Global Revenue Market (Billion US$), 2024 – 2028
Figure-53: Johnson & Johnson – Global Revenue Market (Billion US$), 2018 – 2023
Figure-54: Johnson & Johnson – Forecast for Global Revenue Market (Billion US$), 2024 – 2028
Figure-55: AbbVie Inc. – Global Revenue Market (Billion US$), 2018 – 2023
Figure-56: AbbVie Inc. – Forecast for Global Revenue Market (Billion US$), 2024 – 2028
Figure-57: AstraZeneca plc – Global Revenue Market (Billion US$), 2018 – 2023
Figure-58: AstraZeneca plc – Forecast for Global Revenue Market (Billion US$), 2024 – 2028

List of Tables

Table-01: China – Oncology Drugs Market Share by Therapy (Percent), 2018 – 2023
Table-02: China – Forecast for Oncology Drugs Market Share by Therapy (Percent), 2024 – 2028
Table-03: China – Oncology Drugs Market Share by Indication (Percent), 2018 – 2023
Table-04: China – Forecast for Oncology Drugs Market Share by Indication (Percent), 2024 – 2028
Table-05: China – Oncology Drugs Market Share by Drugs (Percent), 2018 – 2023
Table-06: China – Forecast for Oncology Drugs Market Share by Drugs (Percent), 2024 – 2028